Information  X 
Enter a valid email address

Motif Bio PLC Ord 1P (MTFB)

Date Time Source Announcement
24 Jun 2019 7:00 am
RNS
Motif Bio Presents New Iclaprim Data - ASM Microbe
20 Jun 2019 4:35 pm
RNS
Price Monitoring Extension
19 Jun 2019 5:08 pm
RNS
Holding(s) in Company
  5:08 pm
RNS
Holding(s) in Company
18 Jun 2019 4:05 pm
RNS
Holding(s) in Company
14 Jun 2019 9:04 am
RNS
Holding(s) in Company
  9:04 am
RNS
Holding(s) in Company
12 Jun 2019 5:52 pm
RNS
Holding(s) in Company
06 Jun 2019 7:00 am
RNS
Receipt of FDA Meeting Minutes
31 May 2019 3:15 pm
RNS
Result of AGM
  10:28 am
RNS
Holding(s) in Company
  10:28 am
RNS
Holding(s) in Company
29 May 2019 11:36 am
RNS
Holding(s) in Company
22 May 2019 1:50 pm
RNS
AGM Statement
  7:00 am
RNS
Orphan Disease Opportunity for Iclaprim
21 May 2019 7:00 am
RNS
Iclaprim Data presented at ASM Microbe 2019
20 May 2019 6:14 pm
RNS
Holding(s) in Company
  6:14 pm
RNS
Holding(s) in Company
03 May 2019 6:25 pm
RNS
Meeting with US FDA held as planned
01 May 2019 7:00 am
RNS
Motif Signs Agreement with Lamellar Biomedical
26 Apr 2019 7:01 am
RNS
Notice of AGM
  7:00 am
RNS
Appointment of Andrew Powell to Board of Directors
16 Apr 2019 7:00 am
RNS
Motif Presents New Iclaprim Data at ECCMID 2019
15 Apr 2019 7:00 am
RNS
Fiscal Year 2018 Results
04 Apr 2019 7:00 am
RNS
Motif Bio to Present Iclaprim Data at ECCMID 2019
02 Apr 2019 5:43 pm
RNS
Holding(s) in Company
  5:43 pm
RNS
Holding(s) in Company
01 Apr 2019 3:28 pm
RNS
Holding(s) in Company
  2:17 pm
RNS
Holding(s) in Company
26 Mar 2019 7:00 am
RNS
Motif Bio Raises �2.7m (US$3.55m)
25 Mar 2019 9:49 am
RNS
Proposed Equity Fundraise
20 Mar 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Motif Bio Granted Meeting with U.S. FDA
18 Mar 2019 7:00 am
RNS
Appointment of Bruce Williams as Interim Chairman
15 Mar 2019 7:01 am
RNS
Holding(s) in Company
  7:01 am
RNS
Holding(s) in Company
07 Mar 2019 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
19 Feb 2019 7:00 am
RNS
Conference Call and Webcast
18 Feb 2019 7:00 am
RNS
Amendment Agreement with Hercules Capital
15 Feb 2019 4:28 pm
RNS
Holding(s) in Company
  4:28 pm
RNS
Holding(s) in Company
  4:26 pm
RNS
Holding(s) in Company
14 Feb 2019 7:00 am
RNS
Complete Response Letter from the FDA
05 Feb 2019 7:00 am
RNS
Exercise of Warrants
23 Jan 2019 4:31 pm
RNS
Exercise of Warrants
01 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
31 Oct 2018 7:00 am
RNS
Jefferies London Healthcare Conference
30 Oct 2018 4:35 pm
RNS
Price Monitoring Extension
16 Oct 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
03 Oct 2018 8:01 am
RNS
Motif Bio Presents New Iclaprim Data at IDWeek
28 Sep 2018 7:01 am
RNS
Motif Bio Notes Statement from Amphion Innovations
25 Sep 2018 7:00 am
RNS
Half-year Report
20 Sep 2018 7:00 am
RNS
Upcoming Scientific Conferences
05 Sep 2018 7:00 am
RNS
Iclaprim Data presented at ESCMID/ASM Conference
29 Aug 2018 4:35 pm
RNS
Price Monitoring Extension
21 Aug 2018 7:15 am
RNS
Motif Bio notes statement from Amphion Innovations
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t